Light donald w (26 Ergebnisse)

Zustand: Good. 1st Edition. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Zustand: Good. 1st Edition. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.…

Paperback. Zustand: Very Good. Illustrated. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

Zustand: Very Good. Former library copy. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Zustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has soft covers. In good all round condition. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,350grams, ISBN:9780231146937.

Hardcover. Zustand: Good. No Jacket. Missing dust jacket; Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.

Paperback. Zustand: Brand New. 167 pages. 8.25x5.50x0.50 inches. In Stock.

Zustand: New. Editor(s): Light, Don. Series: Columbia / SSRC Book (Privatization of Risk). Num Pages: 184 pages, figures. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 208 x 142 x 11. Weight in Grams: 254. Series: Columbia / SSRC Book (Privatization of Risk). 184 pages, illustrations. Editor(s): Light, Don. Cateogry: (P) Professional & Vocational. BIC Classification: MMG. Dimension: 208 x 142 x 11. Weight: 254. . 2010. Paperback. . . . . Books ship from the US and Ireland.…

Zustand: New. In English.

Zustand: Good. Good condition. Good dust jacket. A copy that has been read but remains intact. May contain markings such as bookplates, stamps, limited notes and highlighting, or a few light stains.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

hardcover. Zustand: Befriedigend. Seiten; 9780262121095.4 Gewicht in Gramm: 2.

Zustand: New. In English.

Zustand: New. In English.

Zustand: New. In English.

Paperback. Zustand: Brand New. 280 pages. 8.27x5.83x0.59 inches. In Stock.

Zustand: New. Num Pages: 280 pages, 31 black & white illustrations, biography. BIC Classification: JPQB; MB; MBN; MMG; MQP. Category: (P) Professional & Vocational. Dimension: 210 x 148. . . 2014. 1st ed. 2015. Paperback. . . . . Books ship from the US and Ireland.

Zustand: New. Drawing on key concepts in sociology and management, this history describes a remarkable institute that has elevated medical research and worked out solutions to the troubling practices of commercial pharmaceutical research. Good Pharma is the answer to Goldacre's Bad Pharma: ethical research without commercial distortions. Num Pages: 304 pages, 48 figures. BIC Classification: JFMG; MBGR; MMG. Category: (P) Professional & Vocational. Dimension: 243 x 214 x 23. Weight in Grams: 580. . 2015. 2015th Edition. Hardcover. . . . . Books ship from the US and Ireland.…

Hardcover. Zustand: Brand New. 1st edition. 280 pages. 9.75x6.50x1.00 inches. In Stock.

Zustand: New. pp. 184.

Hardcover. Zustand: Brand New. 128 pages. 8.27x5.67x0.63 inches. In Stock.

Taschenbuch. Zustand: Neu. Good Pharma | The Public-Health Model of the Mario Negri Institute | Donald W. Light (u. a.) | Taschenbuch | xviii | Englisch | 2017 | Palgrave Macmillan | EAN 9781349678402 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Zustand: New. &Uumlber den AutorrnrnEdited by Don LightInhaltsverzeichnisChapters include: Donald Light, Bearing the Risks of Prescription Drugs Sheila Weiss Smith (University of Maryland), The FDA: Inadequate Protection from .

Buch. Zustand: Neu. Neuware - Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions.The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected.Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs. The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters What is the effect of giving the private sector and markets a greater role and reducing public oversight This volume considers whether current rules and incentives put patients' health at greater risk, the effect of the expansion of disease categories, the industry's justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective.Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks.Additional Columbia / SSRC books on the privatization of risk and its implications for Americans:Bailouts: Public Money, Private ProfitEdited by Robert E. WrightDisaster and the Politics of InterventionEdited by Andrew LakoffHealth at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. HackerLaid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. NewmanPensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein.…